Table 1.
Comparison of clinical characteristics among participants according to hepatic steatosis in study participants (n = 1969).
| Characteristics | Hepatic Steatosis (−) (n = 1143) |
Hepatic Steatosis (+) (n = 826) |
p |
|---|---|---|---|
| Age (year) | 54.3 ± 14.2 | 55.7 ± 12.6 | 0.027 |
| Male gender (%) | 35.9 | 42.9 | 0.002 |
| Smoking history (%) | 10.7 | 13.4 | 0.064 |
| Alcohol history (%) | 21.3 | 20.4 | 0.604 |
| DM (%) | 7.0 | 15.3 | <0.001 |
| Hypertension (%) | 20.5 | 31.1 | <0.001 |
| SBP (mmHg) | 128.8 ± 20.0 | 135.7 ±18.7 | <0.001 |
| DBP (mmHg) | 75.7 ± 11.8 | 79.0 ± 10.9 | <0.001 |
| Body height (cm) | 160.2 ± 8.4 | 160.8 ± 9.0 | 0.194 |
| Body weight (kg) | 60.7 ± 10.7 | 69.5 ± 12.7 | <0.001 |
| Body mass index (kg/m2) | 23.6 ± 3.4 | 26.8 ± 3.7 | <0.001 |
| Laboratory parameters | |||
| WBC (×103/μL) | 5.8 ± 1.5 | 6.5 ± 1.8 | <0.001 |
| Hemoglobin (g/dL) | 13.8 ± 1.6 | 14.2 ± 1.7 | <0.001 |
| Platelet (×103/μL) | 261.5 ± 67.8 | 271.0 ± 68.5 | 0.002 |
| Fasting glucose (mg/dL) | 95.1 ± 21.0 | 106.8 ± 32.4 | <0.001 |
| Triglyceride (mg/dL) | 87 (64–125) | 134 (98–188.25) | <0.001 |
| Total cholesterol (mg/dL) | 199.4 ± 37.3 | 202.7 ± 37.7 | 0.059 |
| HDL-cholesterol (mg/dL) | 56.3 ± 13.9 | 48.2 ± 11.2 | <0.001 |
| LDL-cholesterol (mg/dL) | 117.7 ± 32.8 | 123.6 ± 35.3 | <0.001 |
| AST (U/L) | 25.2 ± 8.0 | 29.7 ± 14.2 | <0.001 |
| ALT (U/L) | 20.4 ± 12.9 | 33.0 ± 23.5 | <0.001 |
| Creatinine (mg/dL) | 0.94 ± 0.25 | 0.95 ± 0.28 | 0.381 |
| eGFR (mL/min/1.73 m2) | 89.7 ± 17.2 | 88.8 ± 15.3 | 0.206 |
| Uric acid (mg/dL) | 5.5 ± 1.5 | 6.0 ± 1.5 | <0.001 |
Abbreviations: DM, diabetes mellitus; SBP, systolic blood pressure; DBP, diastolic blood pressure; WBC, white blood cell; HDL, high-density lipoprotein; LDL, low-density lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; eGFR, estimated glomerular filtration rate.